Claude independently completes the gene therapy injection in mouse brains
The story so far
No overview yet — start with the coverage timeline below.
Developments
2 developments
- 1 Nov, 15:15 · 1 reportsAI successfully treated epilepsy in miceITHome · AI:Exin Therapeutics successfully had an AI agent perform brain surgery on a mouse.
- 31 Oct, 03:42 · 1 reportsClaude model independently selects gene therapy and surgeryThe Decoder:A Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making
Coverage timeline
Follow the coverage to see every side of the story.
- ITHome · AIExin Therapeutics successfully had an AI agent perform brain surgery on a mouse.
Exin Therapeutics successfully had an AI agent control a robotic arm to inject a drug for treating epilepsy in a mouse, with the surgical process autonomously completed by the Anthropic Sonnet model for drug selection, brain region localization, and injection, under the full supervision of a veterinarian who needed to approve each step. The AI agent observed the injection site during the surgery through a camera, and finally injected 250 nanoliters of the drug, with the mouse recovering well. The Anthropic Opus 5.5 model refused to execute the surgery upon detecting biologically related content.
- The DecoderFeaturedA Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making
The research team allowed Claude Sonnet 5 to autonomously select gene therapy, brain regions, and injection coordinates in an epilepsy mouse model, and operated a custom surgical device to complete the injection, only providing the instruction 'reduce epilepsy seizures'.